Nadia Quignot

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Venues

Breast cancer research and treatment

EJHaem

Bone marrow transplantation

Thrombosis and haemostasis

Certara France

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Certara France May 01 2018

France

Director/PhD :: Evidence and Access

Publications

Cyrille Hulin, Nadia Quignot, Heng Jiang, Hakima Mechiche, Gaëlle Désaméricq
Carfilzomib use in patients with relapsed/refractory multiple myeloma in France: A national retrospective cohort study. EJHaem 5 (4) (2024)
Stephanie H Read, Nadia Quignot, Raissa Kapso-Kapnang, Erin Comerford, Ying Zheng, Corona Gainford, Medha Sasane, Anne-Lise Vataire, Laure Delzongle, Francois-Clement Bidard
Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database. Breast cancer research and treatment (2024)
Stephanie H Read, Nadia Quignot, Raissa Kapso-Kapnang, Erin Comerford, Ying Zheng, Corona Gainford, Medha Sasane, Anne-Lise Vataire, Laure Delzongle, Francois-Clement Bidard
Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database. Breast cancer research and treatment 204 (3) (2024)
Stephanie H Read, Nadia Quignot, Raissa Kapso-Kapnang, Erin Comerford, Ying Zheng, Corona Gainford, Medha Sasane, Anne-Lise Vataire, Laure Delzongle, Francois-Clement Bidard
Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database. Breast cancer research and treatment 204 (3) (2024)
Cyrille Hulin, Nadia Quignot, Heng Jiang, Hakima Mechiche, Gaëlle Désaméricq
Carfilzomib use in patients with relapsed/refractory multiple myeloma in France: A national retrospective cohort study. EJHaem 5 (4) (2024)
Stephanie H Read, Nadia Quignot, Raissa Kapso-Kapnang, Erin Comerford, Ying Zheng, Corona Gainford, Medha Sasane, Anne-Lise Vataire, Laure Delzongle, Francois-Clement Bidard
Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database. Breast cancer research and treatment 204 (3) (2024)
Nadia Quignot, Heng Jiang, Indraraj Umesh Doobaree, Jan Lehmann, Ola Ghatnekar
Healthcare Resource Utilization and Cost Burden of BCG-Treated Non-Muscle Invasive Bladder Cancer Patients in Germany: A Retrospective Claims Analysis. ClinicoEconomics and outcomes research : CEOR 15 (2023)
David Michonneau, Nadia Quignot, Heng Jiang, Dawn Reichenbach, Maebh Kelly, Anita Burrell, Xiang Zhang, Kris Thiruvillakkat, Florent Malard
Clinical and economic burden associated with graft-versus-host disease following allogeneic hematopoietic cell transplantation in France. Bone marrow transplantation (2023)
David Michonneau, Nadia Quignot, Heng Jiang, Dawn Reichenbach, Maebh Kelly, Anita Burrell, Xiang Zhang, Kris Thiruvillakkat, Florent Malard
Clinical and economic burden associated with graft-versus-host disease following allogeneic hematopoietic cell transplantation in France. Bone marrow transplantation (2023)
Laurent Bertoletti, Gaelle Gusto, Artak Khachatryan, Nadia Quignot, Jose Chaves, Audrey Moniot, Ruth Mokgokong
Effectiveness and Safety of Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism: A Nationwide Comparative Cohort Study in France. Thrombosis and haemostasis 122 (8) (2022)
Nadia Quignot, Witold Wiecek, Billy Amzal, Jean-Lou Dorne
The Yin-Yang of CYP3A4: a Bayesian meta-analysis to quantify inhibition and induction of CYP3A4 metabolism in humans and refine uncertainty factors for mixture risk assessment. Archives of toxicology 93 (1) (2018)

Nadia Quignot.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nadia Quignot